Background: Systemic lupus erythematosus (SLE) affects people in childhood (childhood onset) or in adulthood (adult onset). Observational studies that have previously compared childhood-onset versus adult-onset SLE were often restricted to 1 ethnic group, or to a particular area, with a small sample size of patients. We aimed to systematically compare childhood-onset versus adultonset SLE through a meta-analysis.
Introduction
Autoimmune diseases have not well been studied through randomized controlled trials. However, even if small prospective, retrospective, and case-control studies were commonly used to study those diseases, they have gradually been able to show the impact of autoimmune diseases on the population.
Systemic lupus erythematosus (SLE) is one among the common autoimmune disorders affecting a large number of female patients. [1] Even if it is often misdiagnosed or remains undiagnosed by physicians, several important classifications have been proposed according to recent guidelines. [2] The diagnosis of SLE is based on 17 important criteria, whereby a diagnosis of SLE could be made based on 4 of the criteria, including at least 1 of the 11 clinical criteria and 1 of the 6 immunological criteria or by a biopsy-proven nephritis compatible with SLE in the presence of antinuclear antibodies (ANAs) or anti-double stranded DNA antibodies (ds-DNA). [3] SLE affects people in childhood (childhood-onset) or in adulthood (adult-onset). However, observational studies that have previously compared childhood-onset versus adult-onset SLE were often restricted to 1 ethnic group, [4] or to a particular area, [5] with a small sample size of patients. [6] Childhood-onset versus adult-onset SLE were not compared on an International or most probably on a worldwide basis (including patients from different parts of the world) to know whether the differences could be applied throughout any population. Therefore, we aimed to systematically compare childhood-onset versus adultonset SLE using a large number of patients that were extracted from studies based on different regions, with different ethnic groups, in order to obtain a generalized outcome.
Methods

Data sources and searched strategies
Data sources included (1) MEDLINE/PubMed database of medical research articles; (2) EMBASE database; (3) Cochrane library; (4) www.ClinicalTrials.gov; (5) Reference lists of suitable publications; (6) Google scholar; (7) Official websites of several journals of rheumatology.
Searched strategies
The following terms were used in the search process:
(1) "systemic lupus erythematosus," "childhood," and "adult"; (2) "systemic lupus erythematosus" and "childhood"; (3) "systemic lupus erythematosus" and "adult-onset"; (4) "childhood-onset systemic lupus erythematosus"; (5) "adult-onset systemic lupus erythematosus"; (6) "childhood onset systemic lupus erythematosus" and "adult onset systemic lupus erythematosus."
The abbreviation "SLE" was also used in this search process to replace its full-form.
Only English publications were searched.
Inclusion and exclusion criteria
Studies that satisfied the inclusion criteria were
(1) Studies that compared childhood-onset versus adult-onset SLE; (2) Studies that reported clinical outcomes which were observed between childhood-onset versus adult-onset SLE; (3) Studies that reported their data in the form of dichotomous data (number of events), which could be used in this analysis.
Studies were excluded based on the fact that (1) They did not compare childhood-onset with adult-onset SLE; (2) They did not report adverse clinical outcomes as their endpoints; (3) They reported data in a form that could not be used in this meta-analysis; (4) They were duplicate studies or replicated themselves through different searched databases.
Types of participants, outcomes, and definitions
This analysis involved participants with childhood-onset and adult-onset SLE, respectively. Onset of SLE before the age of 17 years was classified as childhood-onset, whereas SLE onset after the age of 17 years, but before the age of 50 years, was considered as adult-onset SLE in this analysis. Late-onset participants who acquired SLE after the age of 50 years were not included. Endpoints that were assessed were first of all based on systemic involvement such as The clinical features that were reported in each study have been summarized in Table 1 . 2.9. Data extraction and review Data were extracted by 2 independent reviewers (PKB and AK). All the relevant information to be used in this analysis was collected. The clinical features that were reported, the age of disease onset, the types of participants, the total number of participants that were extracted from each study, the total number of events that were reported, were all recorded. As baseline features of the participants were seldom reported, we could not include these data in our analysis.
During this data extraction and data collection process, if ever any disagreement occurred, it was discussed between the 2 reviewers. However, if a final decision could not be made, the third reviewer (FH) was called to discuss and solve the issue.
As all the studies which were included in this analysis were observational studies, the Newcastle Ottawa Scale (NOS) was used to assess the methodological quality of the studies. NOS has been refined on the basis of expertise and experience whereby it was used in several projects. [30] NOS assessment involved a minimum number of zero star to a maximum number of 9 stars depending on the quality of the study being assessed. The region where these studies were conducted and the number of stars allotted following the NOS assessment have been listed in Table 2 .
Statistical analysis
The latest version of the RevMan software (version 5.3) was used to carry out this analysis whereby risk ratios (RRs) and 95% confidence intervals (95% CIs) were used as the statistical parameters. However, a short coming that often affects metaanalyses is the presence of inconsistency across studies during subgroup analysis. [31] 
Results
Searched outcomes
The PRISMA study guideline was used. [32] A total number of 1432 publications were obtained. A first elimination was directly carried out based upon assessment of the titles and abstracts whereby 1345 articles were rejected. Further eliminations were based on (1) the study was a meta-analysis (1); (2) the studies did not include any comparative group (14); (3) the studies involved late-onset SLE participants (13); (4) the studies were duplicates (36) .
Finally, only 23 articles were selected for this analysis ( Fig. 1 ).
Main features of the studies which were included
The types of study that were reported, the number of participants who were classified in the childhood-onset and the adult-onset SLE groups, respectively, and the time period of patients' enrollment have all been listed in Table 3 .
A total number of 10,261 participants (1560 participants with childhood-onset SLE and 8701 participants with adult-onset SLE) who were enrolled from the year 1980 to 2013 were included in this analysis.
System involvement
Results of this current analysis showed that compared with childhood-onset SLE, pulmonary involvement was significantly higher with adult-onset SLE with RR: 1.51, 95% CI: 1.18 to 1.93; P = .001, I 2 = 0% (Fig. 2 ). Gastrointestinal involvement, dermatological involvement, musculoskeletal involvement, and neuropsychiatric involvement as a whole were not significantly different between childhood-onset and adult-onset SLE with RR: 1.18, 95% CI: 0.76 to 1.86; P = .46, I 2 = 2%, RR: 0.69, 95% CI: 0.37 to 1.29; P = .24, I 2 = 0%, RR: 0.84, 95% CI: 0.51 to 1.39; P = .50, I 2 = 0% and RR: 0.94, 95% CI: 0.67 to 1.31; P = .70, I 2 = 48%, respectively, as shown in Fig. 2 . However, neurological involvement was significantly higher in childhood-onset SLE with RR: 0.60, 95% CI: 0.44 to 0.80; P = .0006, I 2 = 0% (Fig. 2) . A fixed effects model was used to assess these outcomes.
A random effects model was used to assess several other outcomes. This analysis showed renal involvement to be significantly higher with childhood-onset SLE with RR: 0.65, 95% CI: 0.55 to 0.77; P = .00001, I 2 = 76% as shown in Fig. 3 . However, cardiovascular and hematological involvement as a whole were not significantly different with childhood-onset or adult-onset SLE with RR: 1.02, 95% CI: 0.59-1.77; P = .93, I 2 = 50% and RR: 0.93, 95% CI: 0.74 to 1.17; P = .54, I 2 = 68%, respectively (Fig. 3) .
Rheumatological and connective tissue involvement
Raynaud phenomenon and photosensitivity were significantly higher in adult-onset SLE with RR: 1.29, 95% CI: 1.04 to 1.60; P = .02, I 2 = 29% and RR: 1.08, 95% CI: 1.01 to 1.17; P = .03, I 2 = 46%, respectively (Fig. 4) . On the contrary, oral ulcers were significantly higher with childhood-onset SLE with RR: 0.85, 95% CI: 0.77 to 0.94; P = .001, I 2 = 0% (Fig. 4) . However, alopecia, serositis, and myositis were not significantly different with RR: 0.97, 95% CI: 0.69 to 1.36; P = .86, I 2 = 35%, RR: 1.03, 95% CI: 0.86 to 1.22; P = .77, I 2 = 0%, and RR: 0.46, 95% CI: 0.11 to 1.91; P = .28, I 2 = 51%, respectively (Fig. 4) . This current result also showed malar rash to significantly favored adult-onset SLE and affected patients with childhood-onset SLE to a higher extent with RR: 0.84, 95% CI: 0.75 to 0.94; P = .002, I 2 = 70% (Fig. 5) . However, arthritis and discoid rash were similarly manifested between childhood-onset and adult-onset SLE with RR: 1.04, 95% CI: 0.98 to 1.11; P = .21, I 2 = 69% and RR: 1.04, 95% CI: 0.72 to 1.50; P = .83, I 2 = 63%, respectively (Fig. 5) .
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Studies Reported outcomes Follow-up periods
Brunner et al [7] Ocular damage, neuropsychiatric damage, renal damage, pulmonary damage, cardiovascular damage, peripheral vascular damage, gastrointestinal damage, skin damage, diabetes damage, patients with any renal involvement, WHO classification of the first renal biopsy: class I-V
Following disease
Carreño et al [8] Arthritis, arthralgia, malar rash, fever, Raynaud, pleuritis, vasculitis, articular manifestation, discoid rash, photosensitivity, oral ulcers, cutaneous vasculitis, pericarditis, renal disorder, neurologic disorder, hematologic disorder, hemolytic anemia, leukopenia, lymphopenia, thrombocytopenia
At the onset and following disease Fatemi et al [9] Arthritis, malar rash, oral ulcer, seizure, psychosis, peripheral neuropathy, valvular heart disease, myocarditis, pericarditis, pleurisy, nephritis, hemolytic anemia, thrombocytopenia, leukopenia
Feng et al [10] Arthritis, renal involvement, fever, malar rash, alopecia, photosensitivity, oral ulcers, serositis, pleuritis, pericarditis, vasculitis, CNS involvement, discoid rash, myositis, thrombocytopenia, leukopenia
Following disease Font et al [11] Malar rash, discoid lesion, subacute cutaneous lesion, photosensitivity, oral ulcers, arthritis, serositis, nephropathy, neurological involvement, thrombocytopenia, hemolytic anemia, fever, Raynaud phenomenon, livedo reticularis, thrombosis, myositis, lung involvement, chorea, sicca syndrome, lymphadenopathy
At the onset and following disease Gómez et al [12] Malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, pleuritis, pericarditis, renal involvement, neurologic disorder, thrombocytopenia, leukopenia, hemolytic anemia, Raynaud phenomenon, alopecia, fever, lymphadenopathy, sicca syndrome, thrombosis
At diagnosis/onset Ramírez Gómez et al [13] Fever, myalgia, xerophthalmia, sicca syndrome, oral ulcers, chorea, TIA, CVA, cranial nerve lesion, hemolytic anemia, malar rash, thrombocytopenia, arthritis, photosensitivity, discoid rash, pleuritis, psychosis, seizure, leukopenia, lymphopenia
Gormezano et al [14] Monoarthritis, oligoarthritis, polyarthritis, myositis, fever, adenomegaly, hepatomegaly, splenomegaly, malar rash, discoid rash, photosensitivity, mucosal ulcers, alopecia, Raynaud phenomenon, pleuritis, pericarditis, neuropsychiatric involvement, CNS involvement, renal involvement
Gormezano et al [15] Fever, adenomegaly, hepatomegaly, splenomegaly, malar rash, discoid rash, photosensitivity, mucosal ulcers, alopecia, cutaneous vasculitis, arthritis, myositis, serositis, neuropsychiatric involvement, nephritis, multiple hemorrhagic manifestations, leukopenia, lymphopenia, thrombocytopenia
At diagnosis/onset Hersh et al [16] Renal involvement, pulmonary involvement, seizures, myocardial infarction At diagnosis Hersh et al [17] Mortality
Following disease Hoffman et al [18] Malar rash, photosensitivity, alopecia, oral ulcers, discoid rash, xerostomia, xerophthalmia, fatigue, Raynaud phenomenon, fever, arthralgia, arthritis, myalgia, pleuritis, pericarditis, glomerulonephritis, headache, depression, encephalopathy, seizures, cerebrovascular accidents, psychosis, leukopenia, lymphopenia, thrombocytopenia, hemolytic anemia, thrombosis.
Following disease Janwityanujit et al [19] Fever, malar rash, photosensitivity, oral ulcer, discoid rash, vasculitis, Raynaud phenomenon, musculoarthritis, pleuropericarditis, adenopathy, neuropsychiatric, renal involvement, hematologic involvement, pulmonary involvement, gastrointestinal involvement, cardiac involvement, anemia, leukopenia, thrombocytopenia
At onset
Joo et al [20] Seizure, arthritis, musculoskeletal involvement Following disease das Chagas Medeiros et al [21] Dermatological manifestations, photosensitivity, arthritis, nephritis, lymphopenia, hemolytic anemia, thrombocytopenia, serositis, seizure, psychosis, cutaneous vasculitis, cardiovascular diseases, death
Following disease
Mok et al [22] Arthritis, alopecia, Raynaud phenomenon, malar rash, photosensitivity, discoid lesions, oral ulcers, leukopenia, lymphopenia, thrombocytopenia, hemolytic anemia, lymphadenopathy, serositis, psychosis, seizure, neuropsychiatric, renal involvement, cutaneous vasculitis, ocular involvement, neuropsychiatric involvement, renal involvement, pulmonary involvement, cardiovascular involvement, gastrointestinal involvement, musculoskeletal involvement, dermatological involvement At onset and following disease Pande et al [23] Joint involvement, fever, photosensitivity, malar rash, alopecia, hepatomegaly, splenomegaly, lymphadenopathy, renal disease, cardiac involvement, seizures, psychosis, pulmonary involvement, gastrointestinal involvement, Raynaud phenomenon, vasculitis, thrombosis, anemia, leukopenia, lymphopenia, thrombocytopenia
Rood et al [24] Fever, lymphadenopathy, hepatosplenomegaly, arthritis, malar rash, alopecia, oral ulcers, photosensitivity, Raynaud phenomenon, vasculitis, discoid lesions, renal disorders, pleuritis, pericarditis, headache, seizure, psychosis, anemia, thrombocytopenia, leukocytopenia, lymphocytopenia
Sassi et al [25] Malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, nephritis, neurologic disorders, hematologic disorders, hemolytic anemia, leuko/lymphopenia, thrombocytopenia
At onset Sousa et al [26] Malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, serositis, renal involvement, neurologic disorders, hematologic disorders
Tu et al [27] Neurological involvement, seizure, stroke, psychological symptoms, anemia, leukopenia, thrombocytopenia
Tucker et al [28] Myositis, mortality, rash, arthritis, renal involvement, CNS involvement, hematologic involvement. Following disease Tucker et al [29] Ocular manifestation, neuropsychiatric, renal involvement, pulmonary involvement, cardiovascular involvement, gastrointestinal involvement, musculoskeletal involvement At diagnosis A = adult; C = childhood; CNS = central nervous system; CVA = cerebrovascular accident; SLE = systemic lupus erythematosus; TIA = transient ischemic attack; WHO = World Health Organization.
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Hematological manifestations
When hematological involvement was further subdivided, childhood-onset SLE was associated with significantly higher hemolytic anemia, thrombocytopenia, leukocytopenia, and lymphopenia with RR: 0.69, 95% CI: 0.58 to 0.81; P = .00001, I 2 = 39%, RR: 0.85, 95% CI: 0.76 to 0.96; P = .006, I 2 = 10%, RR: 0.83, 95% CI: 0.76 to 0.90; P = .0001, I 2 = 49%, and RR: Table 3 Main features of the studies which were included.
Studies
Type of study
Period of patients' enrollment, y
No. of patients with childhood-onset SLE (n)
No. of patients with adult-onset SLE (n) Brunner et al [7] Prospective 1990-1998 67 131 Carreño et al [8] Prospective -49 130 Fatemi et al [9] Retrospective 1992-2013 180 394 Feng et al [10] Observational -108 1551 Font et al [11] Prospective 1980-1995 34 396 Gómez et al [12] Report 2003 13 259 Ramírez Gómez et al [13] Cohort >1996 230 984 Gormezano et al [14] Observational 1983-2014 8 69 Gormezano et al [15] Retrospective -49 49 Hersh et al [16] Longitudinal 2004-2006 90 795 Hersh et al [17] Longitudinal 2002-2003 98 859 Hoffman et al [18] Observational -55 188 Janwityanujit et al [19] Observational 1990-1992 51 308 Joo et al [20] Prospective 1998-2012 133 979 das Chagas Medeiros et al [21] Observational 2010-2012 60 338 Mok et al [22] Prospective 1991-2003 50 213 Pande et al [23] Retrospective -83 187 Rood et al [24] Observational 1986-1995 31 135 Sassi et al [25] Cross-sectional 2003-2015 89 419 Sousa et al [26] Cross-sectional -89 89 Tu et al [27] Retrospective 1999-2008 12 15 Tucker et al [28] Prospective -39 165 Tucker et al [29] Case-control -31 48 Total no. of patients (n) 1560 8701 SLE = systemic lupus erythematosus. Study assessment using the Newcastle Ottawa Scale.
Studies Location/region Stars allotted following NOS assessment
Brunner et al [7] Toronto * * * * * * * Carreño et al [8] Spain * * * * * * * Fatemi et al [9] Iran * * * * * * * * Feng et al [10] China * * * * * * * * Font et al [11] Spain * * * * * * * * Gómez et al [12] Spain * * * * * * * Ramírez Gómez et al [13] Latin-America * * * * * * * * Gormezano et al [14] Brazil * * * * * * * Gormezano et al [15] Brazil * * * * * * * * Hersh et al [16] United States * * * * * * * * Hersh et al [17] San Francisco * * * * * * * * Hoffman et al [18] Belgium * * * * * * Janwityanujit et al [19] Thailand * * * * * * * Joo et al [20] Korea * * * * * * * * das Chagas Medeiros et al [21] Brazil * * * * * * * Mok et al [22] China * * * * * * * * Pande et al [23] India * * * * * * Rood et al [24] Netherland * * * * * * * Sassi et al [25] Brazil * * * * * * * * Sousa et al [26] Portugal * * * * * * * Tu et al [27] Taiwan * * * * * * * * Tucker et al [28] United Kingdom * * * * * * * Tucker et al [29] United States * * * * * * * * NOS = Newcastle Ottawa scale.
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Nervous system manifestations
Seizure was significantly higher with childhood-onset SLE with RR: 0.57, 95% CI: 0.47 to 0.70; P = .00001, I 2 = 31%. However, no significant difference was observed with psychosis, with RR: 0.88, 95% CI: 0.64 to 1.20; P = .40, I 2 = 0% (Fig. 7) .
Other clinical manifestations
Ocular manifestation was significantly higher with childhoodonset SLE, with RR: 0.34, 95% CI: 0.21 to 0.55; P = .00001, I 2 = Figure 2 . System involvement between childhood-onset versus adult-onset SLE (part 1).
Bundhun et al. Medicine (2017) 96:37 Medicine 0%, whereas pleuritis was significantly higher with adult-onset SLE with RR: 1.45, 95% CI: 1.17 to 1.79; P = .0008, I 2 = 0%. However, pericarditis was similarly manifested with RR: 0.84, 95% CI: 0.63 to 1.11; P = .23, I 2 = 40%. Vasculitis and fever were significantly higher with childhoodonset SLE, with RR: 0.51, 95% CI: 0.36 to 0.74; P = .0004, I 2 = 53% and RR: 0.78, 95% CI: 0.68 to 0.89; P = .0002, I 2 = 66%, respectively.
Significant and un-significant outcomes are listed in Table 4 .
Publication bias
A visual assessment of the 3 funnel plots, which were obtained from RevMan, showed a low to moderate risk of publication bias across the studies that assessed the relevant clinical endpoints. The funnel plots have been represented in Figs. 8 to 10.
Discussion
In this analysis, we aimed to compare the clinical features that were associated with childhood-onset versus adult-onset SLE using a large number of participants, which was obtained from several corners around the world. The current results showed significantly more adverse features to be associated with childhood-onset SLE when compared with adult-onset SLE. Neurological and renal involvement were more significant with childhood-onset SLE. Even fever significantly favored adult-onset SLE compared with childhood-onset SLE. When hematological manifestation was further analyzed, hemolytic anemia, thrombocytopenia, leukopenia, and lymphopenia were significantly higher with childhood-onset SLE. However, pulmonary involvement, Raynaud phenomenon, and photosensitivity were significantly higher with adult-onset SLE.
A recent meta-analysis comparing the differences in autoantibody profiles and disease activity and damage score associated with childhood-onset versus adult-onset SLE showed increased anti-ds DNA and anticardiolipin antibodies to be significantly associated with childhood-onset SLE. [33] The authors also suggested more disease activity in this category of SLE patients than adult-onset SLE. This current analysis has further supported their conclusion proving that more adverse clinical manifestations were present with childhood-onset SLE. Another metaanalysis comparing cutaneous manifestations between earlyonset versus late onset SLE showed the latter to be associated with less severe outcomes. [34] However, this current analysis did not involve patients with late-onset (elderly) SLE.
A review article based on the recent updates on the differences between childhood-onset and adult-onset SLE showed the latter to be 10 times more common than the former in United States. However, the authors mentioned that childhood-onset SLE was more severe. [35] Another review article based on the similarities and differences between childhood-onset versus adult-onset SLE showed higher prevalence of renal involvement (nephritis) and central nervous system involvement in children than in adults, further supporting the results of this current analysis. [36] The authors also suggested that additional steroid use and more aggressive treatment strategy should be considered in childhoodonset SLE. Moreover, data from the 2002 to 2010 cycles of the Lupus Outcomes Study showed childhood-onset SLE to significantly increase the risk of not working in adulthood, despite of full control of the disease. [37] This current analysis showed childhood-onset SLE to be more aggressive; therefore, specific therapy with better management should be reserved to this particular subgroup. A few studies showed hematuria to significantly increase the mortality rate in participants with childhood-onset SLE that might have been due to complications associated with the renal organ. [38] However, other studies have concluded that patients with childhood-onset and adult-onset SLE with renal involvement should both be carefully monitored to prevent unwanted outcomes. This analysis satisfied all the criteria which are relevant for a good systematic review and meta-analysis. The methodological quality of the studies which were included were assessed. Robust results which match with the clinical literature were obtained. In addition, the current results have been generalized, and not limited to a specific ethnic group or region.
Novelty
This analysis is new because of several reasons:
(1) It is the first meta-analysis comparing clinical manifestations that were observed between childhood-onset versus adultonset SLE; in contrast, a previously published meta-analysis only compared the laboratory features. results that are related to the differences between these 2 onset-periods of SLE, representing a new feature.
Limitations
This analysis also has several limitations:
(1) In those patients to whom clinical features were not reported following the course of the disease, clinical features at onset of the disease were considered relevant. (2) All the data which were extracted were obtained from observational studies, which could be another limitation. (3) Moderate to less severe heterogeneity was reported in several of the subgroups assessing the clinical features.
Conclusion
Significant differences were observed between childhood-onset and adult-onset SLE. Childhood-onset SLE was associated with significantly higher adverse clinical features whereby neurological involvement, renal involvement, oral ulcers, malar rash, vasculitis, fever, ocular, and hematological manifestations were significantly higher, whereas pulmonary involvement, Raynaud phenomenon, and photosensitivity were significantly higher with adult-onset SLE. However, no significant difference was observed in gastrointestinal involvement, cardiovascular involvement, discoid rash, psychosis, alopecia, serositis, and arthritis. 
